Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
December 9, 2022

Health Canada approves VBI Vaccines’ PreHevbrio for Hepatitis B

Health Canada has granted approval for VBI Vaccines’ PreHevbrio [3-antigen Hepatitis B Vaccine (Recombinant)] to prevent Hepatitis B virus (HBV) in adults.

Micrograph of ground glass hepatocytes, as seen in a chronic hepatitis B infection. Credit: Nephron /